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A B S T R A C T
Macrophages are the preferential cell types to study various aspects of mycobacterial infection. Commonly used
infection models for in-vitro studies are primary macrophages such as human monocyte derived macrophages
(hMDMs) and macrophage like cell lines (THP-1). It is not clear if commercially available THP-1 cells can be
used as hMDMs alternative for in-vitro M.tb infection experiments. We conducted a detailed investigation of the
hMDM and THP-1 response to mycobacterial infection on a comparative basis and assess the most crucial aspects
of infection which are most commonly studied. We assessed mycobacterial uptake and intracellular growth over
time of a pathogenic drug-resistant and drug-susceptible M.tb strains (R179 and H37Rv) through colony forming
units (CFUs). Both strains depicted similar uptake and intracellular growth in hMDMs and THP-1 macrophages
over time (R179, p=0.954) (H37Rv, p=0.922). Cytotoxicity assays revealed a consistent viability up to day 16
post-infection across the strains in both THP-1 and hMDMs (R179, p= 0.271) (H37Rv, p= 0.068). Interestingly,
both cell lines showed similar mycobacterial uptake and cellular viability in both susceptible as well as resistant
M.tb strains. Cytokine/chemokine mRNA analysis through qPCR found no difference between cell types. Further,
cytokine secretion measured through Luminex revealed no difference across the strains. Also, cytokine secretion
analysis showed no difference in both cell lines across strains. In conclusion, our study shows that THP-1 and
hMDMs bacterial uptake, viability and host response to drug-susceptible and drug-resistant mycobacterial in-
fections are similar. Therefore, present study demonstrate that THP-1 cells are suitable substitutes for hMDMs for
in-vitro M.tb infection experiments.
1. Introduction
Macrophages are the first line of defense against any invading pa-
thogen [1] and play a key role in the elimination of mycobacteria. In
susceptible individuals, macrophages provide a niche for its replication
[2], and are therefore studied in-depth in an attempt to unravel the
events at the host-pathogen interface early post-infection. Macrophages
as models for mycobacterial infection studies are thus central to the
advancement of the current understanding of host-pathogen interac-
tions and are widely used amongst researchers in the field.
There are various macrophage models in use which include primary
macrophages as well as macrophage cell lines to study M. tuberculosis
(M.tb) infection. Primary macrophages include human monocyte de-
rived macrophages (hMDMs) and mouse bone marrow-derived macro-
phages (BMDMs). There are a number of cell lines depicting macro-
phage models such as the human THP-1 and U937 and the murine
RAW264.7 and J774 cell lines [3]. The advantage of using macrophages
from Mus musculus is that there is substantially lower variability be-
tween mice when compared to the variability observed in Homo sapiens
[4]. Ex vivo human macrophages as models for infection are however
preferred, with variability between individuals being controlled for best
by increasing sample size. hMDMs are isolated from the natural host
and are comparatively easy to differentiate in vitro from human blood
monocytes. However, to draw blood from humans, ethical permission is
required which is often a lengthy process. In contrast, cell lines are
homogenous, easy to proliferate and easier to maintain in the labora-
tory. There is the disadvantage that cell lines derived from transformed
or immortalized cells have a tendency to be genetically unstable and
may exhibit uncharacteristic/aberrant signaling mechanisms [5].
As mentioned previously, hMDMs are considered to be the first line
of defense against mycobacterial infection due to their extensive role in
stimulating immune response and playing an important role in
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activation of the adaptive immune response and tissue homeostasis [6].
THP-1 is a monocyte leukemia cell line from humans which differ-
entiate into active macrophages after treatment with phorbol 12-myr-
istate 13-acetate (PMA). This cell line has been used extensively to
study monocyte/macrophage mechanisms, their regulatory functions,
nutrient transport and signaling pathways [7].
Therefore, research comparing infection of M.tb to both cells
(hMDMs and THP-1) are scarce. Also, whether they can be used as each
other’s alternative is unclear. Hence, in the present study, we are
comparing hMDM and THP-1 response at various levels to myco-
bacterial infection. Here, for the first time we conduct a head to head
comparison of both cell types using a drug-susceptible (H37Rv) and a
drug-resistant strain (R179) of M.tb through bacterial uptake, host cell
viability, mRNA expression level as well as cytokines secretion upon
infection.
2. Methodology
2.1. Cells and culture medium
Human macrophage-like cells, THP-1 (ATCC-88081201), were cul-
tured in RPMI-1640 supplemented with 10% heat-inactivated fetal calf
serum (Biochrome, Germany). The cells were incubated at 37 ºC in a 5%
CO2 incubator. THP-1 cells were treated with a final concentration of
100 nM Phorbol 12-Myristate 13-Acetate (PMA; Sigma Aldrich, USA)
for 48 h. In the present study, commercially available THP-1 like
macrophages were used, experiments were carried out within 5 pas-
sages to avoid change of cellular properties [8]. Cells were in a healthy
and stable morphological state. The morphology of cells was frequently
examined under a microscope. Cytotoxicity analysis was also performed
to study host cell viability.
For human monocyte derived macrophage cells, phlebotomy was
performed on three healthy individuals (80ml blood) after their written
consent (in accordance with declaration of Helsinki) in Na-Heparin
vacutainers. Ethical permission for the same had been obtained from
the Ethics Committee, Stellenbosch University, Tygerberg campus,
Cape Town (HREC Reference #S17/10/211). Healthy individuals were
selected based on inclusion criteria such as no symptoms of tuberculosis
including clear Chest X-Ray, night sweats and fever. Individuals on
strong medication or any recent past surgery, pregnancy, anemia and
insomnia were among the exclusion criteria. Whole blood from the
recruited participants were further diluted with PBS (Sigma Aldrich,
USA) in 1:1 ratio. This diluted ratio of blood and PBS was gently poured
over the Histopaque (Sigma Aldrich, USA) layer and centrifuged at
804xg for 20min. The buffy coat layer that appears between the blood
plasma and the RBCs, containing the peripheral blood mononuclear
cells (PBMCs) was collected in different tubes and washed twice with
PBS. Total cells obtained was counted and proceeded for monocyte
derived macrophages (MDM) isolation and differentiation.
Cells were cultured from human blood in Teflon jars using RPMI-
1640 (Sigma Aldrich, USA) medium supplemented with 20% hepar-
inized plasma and incubated at 370C, 5% CO2 for 5 days. This allows
the differentiation of monocytes into macrophages. The lids of the
Teflon jars were tightened and placed on ice for 30min. Cells were
collected from Teflon jars using a Pasteur pipette. Each Teflon jar was
washed and pooled into the same tube with cold RPMI-HEPES (Sigma
Aldrich, USA) (4ml per wash). The tubes were spun at 130×g for
10min at 4 ºC with no brake. The pellets were re-suspended in RPMI-
glut and counted. The required volume of heparinized plasma (20%
final), 10% human serum and RPMI-Glut was added to the cell sus-
pension and plated in 24 well culture plates. The cells were incubated
for 2 h at 37 ºC with 5% CO2 for adherence of MDMs.
2.2. Bacterial strains and infection conditions
Two pathogenic M.tb strains R179 (drug-resistant Beijing 220
clinical isolate) and H37Rv (drug-susceptible M.tb strain) were selected
for infection. Mycobacteria were cultured in Middlebrook 7H9 (with
10% OADC and 0.5% glycerol) without Tween 80, as the detergent is
known to affect macrophage uptake and the host response to M.tb [9].
For infection experiments, human macrophages as well as THP-1 cells
were seeded in 24-well ultralow attachment surface culture plates at
0.35×106 cells per well. Both cell types were infected with the two
pathogenic mycobacterial strains at a MOI=2 using the “syringe settle
filtrate” (SSF) method [10] and incubated four hours for bacterial up-
take. A similar uptake (measured by CFUs) of the two strains was ob-
served in both hMDMs and THP-1 cells. The cells were then washed
with phosphate buffered saline (PBS) three times to remove any ex-
tracellular mycobacteria. Cells were incubated for an additional 20/
92 h in complete RPMI medium (24/96 h in total depicting early and
late response to infection). Uninfected hMDMs as well as THP-1 cells
served as the control/uninfected samples.
2.3. RNA extraction
Total RNA from human macrophages and THP-1 cells were ex-
tracted using the RNeasy Plus Mini Kit (QIAGEN, USA) as per the
manufacturer’s instructions. The extraction was performed immediately
following the 24- and 96 hs infection period. The ‘gDNA eliminator’
column included in this kit was used to remove genomic DNA in all
samples. For each experiment, RNA quantity and quality were mea-
sured using Agilent 2100 Bioanalyzer. The RNA with a high RNA in-
tegrity Number (RIN) (≥9) was used for cDNA preparation prior to
quantitative real time PCR experiments.
2.4. Quantitative qPCR
For cDNA preparation 0.5 μg RNA was converted using the
Quantitect R Reverse Transcription Kit (QIAGEN, USA). To ensure the
removal of genomic DNA, ‘gDNA wipe-out buffer’ was added to RNA
(included in the kit) prior to the RNA conversion step. qPCR amplifi-
cation was run on a LightCycler R 96 system (Roche, Germany).
LightCyclerR 480 SYBR Green I Master was used for various differen-
tially expressed genes using QuantiTectR primer assays with 10 μl of
reaction volume. The reference genes (hsUBC and hsGAPDH) were se-
lected conferring to stable expression levels of known cytokines. The
amplification process involves 45 cycles of 95 º C for 10 s followed by
60 º C for 10 s and finally 72 ºC for 10 s. Gene expression fold-changes
was computed for pathogenic infected and uninfected macrophages
using calibrated normalized relative quantities using the equation
N=N0 × 2Cp. All qPCRs were done on RNA extracted from six dif-
ferent experiments. All biological replicates having a positive control
and a non-reverse transcription control was run in triplicate (along with
calibrator) as per the MIQE Guidelines [10].
2.5. Determination of bacterial uptake and viability
Infected cells were lysed using 0.1% Triton X-100. Bacterial uptake
was determined by serial dilution (10−1–10−4) and plating out of
mycobacteria onto 7H11 agar plates. The agar plates were incubated at
37 °C for 5 weeks and CFUs/ml was determined. Bacterial survival
within the infected cells was monitored at 4 h and day 1 to day 16 post-
infection respectively. Fresh media was replaced after every four days
of the culture.
2.6. Cytotoxicity analysis
Both hMDMs and THP-1 like-macrophages were seeded in a 24 well
plate with 0.35× 106 cells/well. Cells were maintained for 16 days
post-infection. Every set of cells including uninfected and infected cells
were processed at 4, 8, 12, 14, and 16 days post-infection respectively.
Fresh media was replaced at every four days of culture. We did not have
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a concern about cellular confluence as THP-1 cells treated with PMA
leads to maturation, differentiation and a very low rate of proliferation,
hence we did not experience any issue with the cellular confluence
during the 16 day experiment.
Cell cytotoxicity was tested with Roche WST-1 Cell Cytotoxicity
Reagent (Roche, USA) in 1:10 dilution of WST-1 reagent to RPMI
complete media. Cells were incubated for 1 h at 37 º C and 5% CO2.
Absorbance was measured at 450 and 630 nm. The difference between
the two absorbance readings was plotted in Excel as percentage values.
2.7. Luminex assay
Sample levels were evaluated using ThermoFisher Luminex kits
12plex PPX-12 (ThermoFisher Custom Procarta-12 Plex) on Bioplex
platform (Bioplex™, BioRad Laboratories). Luminex assay was per-
formed following ThermoFisher protocol and instructions. The assay
was performed by a single technician where all samples were evaluated
in duplicate. All analyte levels included in the kits which are a part of
quality control reagents were within the expected ranges. Co-efficient
of variation of these samples for duplicate runs did not vary a lot be-
tween analytes for both inter and intra plate. The variation range for
duplicate runs was below 20% (5.2%–19.6% range). The standard
curve for all samples ranged from 3.6 to 10000 pg/ml. Bioplex Manager
Software version 4.1.1 was used for data analysis.
2.8. Statistical analysis
Real time qPCR data was analyzed using Light Cycler 96 SW 1.1
Software and Graph-pad Prism V7. Relative Expression of the cytokines
was measured through the software in response to the Calibrator and
non-transcription control. The relative expression data of the cytokines
was further analyzed through Graph-pad prism to generate the p-values
through One-Way ANOVA. The p-values were finally generated through
Multiple Testing using Tukey corrections. The data (in triplicate) was
finally plotted in histograms with respective mean and standard de-
viations. Cytotoxicity graphs and CFUs were plotted with an average of
the technical triplicates leading to the mean of all the Biological re-
plicates. Statistical analysis was performed through Graph-pad Prism
V7 software where the percentage of every expressing cell was gener-
ated, and p value was calculated using One-Way ANOVA. Luminex data
was analyzed by One-Way ANOVA using Graph-pad Prism V7 for
Windows (Graph-pad Software, San Diego California, USA).
3. Results
3.1. Determination of colony forming units
Intracellular growth rates were determined by colony forming units
per ml (CFUs/ml) over a period of 16 days (Fig. 1A and B) at 4 h post-
infection, THP-1 cells were infected with 122,000 CFUs/ml of R179 and
131,000 CFUs/ml of H37Rv. Also, at 4 h post-infection, hMDMs were
infected with 124,000 CFUs/ml of R179 and 132,000 CFUs/ml of
H37Rv. CFUs were measured at day 0, 1, 4, 8, 12, 14- and 16-days post-
infection. No difference in the mycobacterial uptake (measured by
CFUs) was observed between the two cell types using R179 (p=0.954)
and H37Rv (p=0.922). Also, there was no difference observed in
mycobacterial uptake between drug-resistant R179 and drug-suscep-
tible H37Rv M.tb pathogenic strains for both THP-1 (p=0.894) and
hMDMs (p= 0.949).
3.2. THP-1 and hMDM viability over-time post-infection
Cell viability was tested in both cell types which included unin-
fected and infected cells (Fig. 2). THP-1 cells had 90 and 88% viability
at day 1 and 4 post-infection with R179, whereas had 93 and 91%
viability at day 1 and 4 post-infection with H37Rv. Cell viability
decreased slightly over time. On the other hand, hMDMs had 89 and
87% viability at day 1 and 4 post-infection with R179 and had 91 and
90% viability at day 1 and 4 post-infection with H37Rv, and like THP-1
cells, viability in hMDMs also decreased slightly over time. Thus, no
significant difference in the cell viability was observed after infection
with drug-susceptible and drug-resistant M.tb strains. It is noteworthy,
that the cell viability was found similar across both cell types, in-
dicating their life-span in vitro post-infection is similar, for both THP-1
and hMDMs (R179, p=0.271) (H37Rv, p=0.168) respectively. There
was also no difference observed in viability between the susceptible
H37Rv and resistant R179 M.tb strains for both THP-1 (p= 0.221) and
hMDMs (p=0.647).
3.3. Determination of cytokine/chemokine mRNA levels in THP-1 and
hMDMs at 24 and 96 h post-infection
We assessed gene expression of the typical pro- and anti-in-
flammatory cytokines and chemokines induced after infection with
M.tb. We did this through qPCR and assessed relative expression of the
genes in uninfected and infected samples (Fig. 3a and b).
On studying relative expression of IL-6, we found that upon infec-
tion with R179, THP-1 and hMDMs had no difference at their mRNA
level at both 24- and 96 hs post-infection. Upon infection with H37Rv,
THP-1 cells showed higher expression at 24 h post-infection
(p= 0.036), but no difference at 96 h post-infection.
IL-12 mRNA levels were similarly expressed at 24 h post-infection
with R179 and H37Rv for both THP-1 cells and hMDMs. However, after
96 h of infection, hMDM showed relatively higher expression as com-
pared to THP-1 cells. Upon infection with R179, hMDM had higher
mRNA level expression (p= 0.044). hMDMs showed higher mRNA
Fig. 1. Colony counts of M.tb from day 0 (at 4 h post infection) up-to day 16
post infection in hMDM and THP-1 cells (Fig. 1A and B). THP-1 cells and
hMDMs are depicted with two different markers at different time points. Both
culture models represent a similar trend with a gradual increase in CFUs/ml up-
to day 16. The data represents the means of results from three different ex-
periments and standard deviation of the means was calculated.
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expression than THP-1 cells upon infection with H37Rv (p=0.001).
Next, we assessed the expression of the chemokines CCL2 and CCL5
upon infection. CCL2 showed no difference upon R179 infection at 24-
and 96 hs post-infection. Relative expression of CCL2 in hMDMs in-
fected with H37Rv was significantly high when compared to that of
THP-1 cells at both 24- and 96 -hs post-infection (p-value < 0.001).
The relative expression of CCL5 on the other hand had no difference
between THP-1 cells and hMDMs after infection with both pathogenic
strains at 24- and 96 -hs post-infection.
THP-1 cells and hMDMs had no difference in IL-1β expression at
both time points across the strains. Interestingly, both cell types showed
a strain-specific response after infection with H37Rv through sig-
nificantly upregulating IL-1β expression. The trend of IL-1β mRNA
expression was consistent in both cell types.
Both TNF-α and IFN-γ had increased expression after infection in
both cell lines at both time points but did not show any significant
differences and followed a similar level of expression. Finally, we
measured the relative expression of IL-10 and observed that THP-1 cells
and hMDMs had elevated levels of the mRNA throughout the 96-h in-
fection period, whereas the THP-1 cells appeared to have an early re-
sponse to infection after infecting with R179. Thereafter, expression
remained similar. The relative expression of IL-10 which is a known
anti-inflammatory cytokine had no major difference in the uninfected
samples rather showed a significant difference in hMDM cells infected
with H37Rv at 24 h when compared to THP-1 cells (p= 0.024). After
studying relative expressions, we can conclude that there is no major
difference observed in cytokines/chemokines mRNA levels between
infected THP-1 and hMDMs at 24 and 96 h post infection. Although
there were significant inter-strain differences in mRNA levels over-time,
this did not contribute to overall significance.
3.4. Secreted cytokine levels between infected THP-1 and hMDMs at 24 and
96 h post-infection
Secreted cytokines measured using cell supernatant did not show
any significant difference across the strains between the two cell lines.
Luminex assay was performed and the secretory cytokines/chemokines
was measured against their standards in duplicates for 24- and 96 -hs
post-infection (Fig. 4). Five different cytokines including IL-6, IL-12, IL-
1β, IFN-γ and TNF-α were measured through Luminex and the data was
analyzed using Graph-pad Prism. The cytokines secretion had no dif-
ference when compared across the strains. It was interesting to note
that all five cytokines did not show any significant difference at 24 h
post-infection across the strains for THP-1 cells and hMDMs (R179,
p=0.861) (H37Rv, p= 0.986). The cytokines were also measured at
96 h post-infection, and still did not show any significant difference as
late expressions across the strains for THP-1 and hMDMs (R179,
p=0.765) (H37Rv, p= 0.826). There was also no difference observed
in cytokines secretion between the susceptible H37Rv and resistant
R179 M.tb strains for both THP-1 (p=0.168) and hMDM (p=0.272)
at 24 h post-infection and THP-1 (p= 0.324) and hMDM (p=0.296) at
96 h post-infection.
4. Discussion
In the present study, we have used two types of macrophage cells
(hMDMs and THP-1) to study host response towards M.tb infection,
both these cell types are widely used to study associations at the host-
pathogen interface [12]. We also focused on comparing a drug-sus-
ceptible and a drug-resistant M.tb strain (H37Rv and R179), hence to
give a clear picture for type of infection and host response. We carefully
selected six cytokines and two chemokines for monitoring mRNA ex-
pression level through qPCR (IL-6, IL-12, IL1β, IFN-γ, TNFα, IL-10,
CCL2 and CCL5). We also measured five signature cytokines (IL-6, IL-
12, IL1β, IFN-γ and TNFα) among the above eight for studying protein
secretion through Luminex. The selected panel of cytokines and che-
mokines were reported to play specific roles in context of M.tb infection
[13]. Importantly, in the present study, we have avoided any external
stimulation, including cell isolation through bead separation, LPS or
any cytokine stimulation such as IFN-γ, hence minimizing any altera-
tion in surface receptors or cytokines expression, which was lacking in
previous studies. There are studies which include activation factors for
cellular differentiation and isolation. Bead separation or magnetic ac-
tivated cell sorting methods for macrophage isolation and other che-
micals-supplementation for macrophage differentiation and in-
tracellular growth are used while reviewing variants of M.tb [14,15].
The main findings of the present study is as follow: 1) we found
similar uptake of bacteria in both cell types (hMDMs and THP-1) at
various time points (up to 16 days) post-infection, both cell types had
similar response with drug-susceptible (H37Rv) and drug-resistant
(R179) pathogenic M.tb strains, 2) the viability of both cell types were
found to be similar at various time points (up to day 16) post-infection,
3) comparison of the mRNA expression level between the two cell types
before and after infection (24 and 96 h), revealed no difference in sig-
nature cytokines (IFN-γ, IL-1β and TNF-α) and chemokine (CCL5),
though some of the cytokines/chemokines differed across both cell
types and 4) comparison of secreted cytokines levels before and after
infection of both cell types, were found to be similar at both time points
(24 and 96 h) across the strains.
Previous studies investigated the comparison of primary and sec-
ondary cell lines including blood macrophages and THP-1 like
Fig. 2. Host cell viability upon infection with M.tb strains was measured
through cytotoxicity assay from day 1 to day 16 post-infection. Histogram de-
picts an average of the uninfected hMDMs and THP-1 s along with infected
hMDMs and THP1 cells. Fig. 2(A): Cytotoxicity analysis of cells infected with
R179. Fig. 2(B): Cytotoxicity analysis of cells infected with H37Rv. The data
represents the means of results from three different experiments and the bars
represent standard deviation of the means.
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macrophages for bacterial uptake measured by colony forming units.
They showed both primary and secondary macrophages CFUs were si-
milar at resting phase i.e. without any activation or stimulation [1].
Another study showed no difference in bacterial uptake in THP-1 and
hMDMs in a control state. But, upon stimulation with p19 (19-kDa M.
tuberculosis glycoprotein), a significant reduction in CFU recovery was
noted. This reduction was still similar in both the cell types indicating
that there is minimal or no significant difference in M.tb infected
hMDMs and THP-1 cells [16]. In the present study, we avoided any kind
of stimulations that could alter surface receptors. Moreover, we per-
formed head-to-head comparison of CFUs for hMDMs and THP-1 which
showed similar CFUs at various time points (up to day 16 post-infec-
tion) for both susceptible and resistant mycobacterial strains (R179,
p=0.954 and H37Rv, p=0.922). Results indicated, both cell types
had similar bacterial uptake (similar CFUs), this has useful implications,
as THP-1 cells can be used as an alternate to human blood macrophages
Fig. 3. (a&b): qPCR-based analysis of pro- and anti-inflammatory cytokines and chemokines in hMDM and THP-I cells after 24 and 96 h of infection with M.tb.
Relative mRNA expression (fold change) of various cytokines and chemokines induced by human cells following infection with twoM.tb strains (R179 and H37Rv) as
analyzed through qPCR (n= 3). GAPDH and UBC used as reference genes. Standard deviation is shown by error bars. One-way-ANOVA with Tukey correction for
multiple comparisons was used to determine p values depicted as (*) where ** = p < 0.05, *** = p < 0.001.
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in in-vitro experiments encompassing M.tb infection (either susceptible
or resistant).
As tissue macrophages originating from circulating mononuclear
monocytes do not need to self-renew, hence the hMDMs do not pro-
liferate in-vitro [16]. Similarly, treating THP-1 cells with PMA leads to
maturation, differentiation and a very low proliferation rate [17–19]. In
the present study, we cultured hMDMs and THP-1 cells up-to day 16
post-infection to study the intra-cellular bacterial growth and the host
cell viability. During the 16 days of the experiments no extracellular
bacterial growth was detected by regular visual inspections using the
microscope. Fresh media was replaced after every 4 days of culture.
Luminex assay was performed at 24- and 96 -hs post-infection (without
any media replacement), hence not effecting the cytokine secretion into
the cell supernatant during this period.
In the present study, host cell viability of both cell types analyzed by
a cell cytotoxicity assay proved to be informative for in-vitro M.tb in-
fection experiments. It was essential to study the uninfected and in-
fected cell viability over time post-infection. Both cell types at MOI of 2
had ≤85% viability up to day 8 post-infection and gradually decreased
by day 16 following the same trend. Previous study showed difference
in cell viability in the two cell lines but at higher MOI (10 and 100).
They reported that upon M.tb infection, hMDMs had higher cell death
compared to THP-1 at MOI of 10 and 100. But, they also showed that at
MOI of 1, there was no significant change in the cytotoxicity between
the two cell lines [21]. Present study agrees with the results of the
previous study, and the viability of both cell types are similar over 16
days post-infection, indicating both cell types have similar survivability
under infection.
We determined the host response of both cell types by quantifying
mRNA expression by qPCR and determination of secreted levels of cy-
tokines and chemokines using Luminex. qPCR is considered to have
high sensitivity and accuracy for gene expression quantification [22].
We carefully selected a panel of six cytokines and two chemokines
which are known to play significant role in M.tb infection.
We found three cytokines (IFN-γ, IL1β, and TNFα) and one che-
mokine (CCL5) to be non-significant between the two cell types at two
time points (24 and 96 h post-infection) across both strains. IFN-γ, is a
known signature cytokine in M.tb infection and regarded as crucial
cytokine to fight against M.tb [23,24]. IFN-γ showed a similar gene
expression by qPCR in both cell types after infection with both sus-
ceptible and resistant strains. Also, we found similar level of secreted
IFN-γ (detected by Luminex assay) from both cell types across suscep-
tible and resistant strains, hence, confirming the qPCR findings. It is
important to note that IFN-γ consistently remained similar in both cell
types, indicating a similar host response from both cell types.
IL-1β did show an early response at 24 h in both the cell types upon
H37Rv infection, though similar in both cell types. The expression re-
duced at later time point (96 h post-infection) and consistently re-
mained similar in both cell types. The secreted levels of IL-1β, de-
termined by luminex assay was found to be similar in both cell types at
Fig. 4. (a&b): Cytokines secretion through Luminex. Luminex was performed in both cell lines hMDMs and THP-1 s upon 24 and 96 h post-infection with H37Rv and
R179 M.tb strains. The data represents the means of results from three different experiments and the bars represent standard deviation of the means.
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24- and 96 hs post-infection. IL-1β is regarded as crucial cytokine for
survival against M.tb infection, previous studies have shown that IL-1β
knock-out mice were more susceptible to M.tb infection [25,26]. Other
important cytokine was TNF-α, which is believed to be responsible in
apoptosis of M.tb infected cells in-vitro [27,28]. Further, secreted levels
and mRNA expression of TNF-α was also found to be similar in both cell
types at 24 and 96 h, these results are in agreement with a the pre-
viously published study [1].
We also measured IL-6, which was shown to be regulated by M.tb to
inhibit type I interferon signaling and, consequently, disease progres-
sion in TB [29]. It was also reported that IL-6 secreted after infection of
macrophages with M.tb inhibits the responses of uninfected macro-
phages to IFN-γ [30]. In the present study, the mRNA levels of IL-6 was
found to be significantly higher in THP-1 cells as compared to hMDMs
at 24 h post-infection with H37Rv, though the expression level were
found to be similar after 96 h. This indicated an early response in THP-1
cells after infection with susceptible M.tb (H37Rv). The expression level
of IL-6 was found to be similar in both cell types at 24 and 96 h after
infection with R179. Since, the secreted levels of IL-6 measured through
luminex was found to be similar at both time points across both M.tb
strains, this indicated that even though the mRNA levels were higher in
THP-1 cells at 24 h, the secreted levels of IL-6 were still found to be
similar.
We measured IL-12 which is known to have agonist and protective
role in mycobacteria infection [31,32]. We found significantly higher
IL-12 in hMDMs when compared with THP-1 cells across the two pa-
thogenic strains at 96 h. On the other hand, mRNA levels of IL-12 was
found to be similar at 24 h. IL-12 is known as an essential marker for
survival after M.tb infection [13]. But, alike IL-6, we found similar se-
creted levels of IL-12 from both cell types at 24 and 96 h post infection
with susceptible and resistant M.tb strains, indicating similar host re-
sponse of both cell types.
Previous study shows the relation of IL-10 with M.tb infection. M.tb
infected THP-1 cells is known to induce IL-10 gene expression [33]. We,
therefore measured IL-10, a known anti-inflammatory cytokine where
THP-1 had higher expression upon H37Rv infection at 24 h when
compared with hMDMs, however, there was no difference at later time
point (at 96 h). The cytokine secretion of IL-10 was found to be similar
for both cell types at 24 and 96 h after infection with R179.
A known chemokine CCL2 showed higher expressions in THP-1 cells
at both early (24 h) and late (96 h) post H37Rv infection. However, the
expression level of CCL2 after infection with R179 was found to be
similar for both cell types at 24 and 96 h. CCL2 is known to maximize
and organize early macrophages in the lungs, which was strongly de-
picted by THP-1 cells as compared to hMDMs. Chemokine CCL5 showed
similar mRNA expression throughout (24 and 96 h post-infection) in
both the cell types across the two strains. CCL5 is speculated to enhance
macrophage M.tb killing and facilitate early dendritic cell accumulation
in the lymph node [13].
An overall similar host response (measured by cytokines/chemo-
kines) at mRNA levels across the two pathogenic strains in both cell
types was observed. There are some minor variations in mRNA levels,
particularly after infection with susceptible strain (H37Rv), but this did
not result in any variation observed in mycobacterial uptake, cellular
viability as well as host response towards cytokines secretion. Host
response towards mRNA expression was found to be consistently similar
after infection with resistance strain R179 as compared to the suscep-
tible H37Rv.
Overall, we observed a similar trend in both the cell types without
any notable significant differences between the two. The results
therefore validate the utility of THP-1 cells to study M.tb infection and
are comparable to the hMDMs response to infection, i.e. THP-1 cells
behave like native human monocyte derived macrophages with regards
to the parameters measured in this study. As an in-depth study to relate
the physiological functions exhibited by these cells, THP-1 cells prove
to be a valuable model exploring macrophage specific genes. Due to
their similarity and relatively similar behavior with native cells, they
have proven to be a valuable model for macrophage differentiation
mechanisms.
Our study has some limitations, we only used two pathogenic M.tb
strains. Though our motive was to compare both susceptible and re-
sistant strains, we will compare more strains in future studies. Also, we
have measured the CFUs and viability of cells up to day 16, thus, we
cannot conclude what happens to bacterial uptake, viability and host
response at later time points. Moreover, we are fully aware that we
should investigate other host response signatures (with broad panel of
cytokines and chemokines).
We therefore conclude that both cell types, i.e. hMDMs and THP-1
have shown similar bacterial uptake (measured by CFUs), cellular
viability and similar host response signature biomarkers to both drug-
susceptible (H37Rv) and drug-resistant (R179) mycobacterial infection.
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